Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Lung Cancer
Trial Locations (5)

6419PC

NOT_YET_RECRUITING

Zuyderland Medical Center, Heerlen

6229HX

NOT_YET_RECRUITING

Maastricht University Medical Center, Maastricht

5623EJ

RECRUITING

Catharina Ziekenhuis Eindhoven, Eindhoven

5664EH

NOT_YET_RECRUITING

St. Anna Ziekenhuis, Geldrop

5504DB

NOT_YET_RECRUITING

Máxima Medisch Centrum, Veldhoven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Eindhoven University of Technology

OTHER

collaborator

Roche BV Netherlands

UNKNOWN

collaborator

Maxima Medical Center

OTHER

collaborator

Zuyderland Medisch Centrum

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

St. Anna Ziekenhuis, Geldrop, Netherlands

OTHER

collaborator

The Netherlands Cancer Institute

OTHER

lead

Catharina Ziekenhuis Eindhoven

OTHER